In a clinical trial with nearly 1,000 participants, people on resmetirom were more likely to see improvement in their condition than those taking a placebo, researchers reported in the New England Journal of Medicine
We believe in getting it right
'cause yes, they can do that, but they can [00:12:00] address appetite dysregulation, they can help with their blood sugar
This is the first direct genetic evidence that variation in the drugs target gene contributes to why some people respond dramatically and others barely move
But the new Medicare benefit comes with caveats, particularly around clinical guidelines and what happens when the short-term program ends
Explore different activities: Pick exercises you like youll stick with them longer